TLR8 Gene

Migration, Crosslink

📖

TLR8 Gene

active

wiki page Created: 2026-04-02T07:19:28 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-tlr8

📖 Wiki Page

gene1533 wordssynced 2026-04-02

TLR8 Gene

Introduction

Tlr8 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-gene"> [@bsibsi2002]
<table> [@gorden2006]
<tr><th colspan="2" style="background:#f0f0f0; text-align:center; font-size:1.1em;">TLR8 Gene</th></tr> [@heil2004]
<tr><td><strong>Gene Symbol</strong></td><td>TLR8</td></tr> [@tanji2013]
<tr><td><strong>Full Name</strong></td><td>Toll-Like Receptor 8</td></tr> [@kawai2007]
<tr><td><strong>Chromosomal Location</strong></td><td>Xp22.2</td></tr> [@heneka2015]
<tr><td><strong>NCBI Gene ID</strong></td><td>[51311](https://www.ncbi.nlm.nih.gov/gene/51311)</td></tr> [@glass2010]
<tr><td><strong>OMIM</strong></td><td>300366</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000101916</td></tr>
<tr><td><strong>UniProt</strong></td><td>[Q9NYK5](https://www.uniprot.org/uniprot/Q9NYK5)</td></tr>
<tr><td><strong>Protein Class</strong></td><td>Pattern Recognition Receptor (TLR family)</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Alzheimer's Disease, Parkinson's Disease, Rheumatoid Arthritis, Viral Infections, Systemic Lupus Erythematosus</td></tr>
</table>
</div>

Overview

...

TLR8 Gene

Introduction

Tlr8 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-gene"> [@bsibsi2002]
<table> [@gorden2006]
<tr><th colspan="2" style="background:#f0f0f0; text-align:center; font-size:1.1em;">TLR8 Gene</th></tr> [@heil2004]
<tr><td><strong>Gene Symbol</strong></td><td>TLR8</td></tr> [@tanji2013]
<tr><td><strong>Full Name</strong></td><td>Toll-Like Receptor 8</td></tr> [@kawai2007]
<tr><td><strong>Chromosomal Location</strong></td><td>Xp22.2</td></tr> [@heneka2015]
<tr><td><strong>NCBI Gene ID</strong></td><td>[51311](https://www.ncbi.nlm.nih.gov/gene/51311)</td></tr> [@glass2010]
<tr><td><strong>OMIM</strong></td><td>300366</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000101916</td></tr>
<tr><td><strong>UniProt</strong></td><td>[Q9NYK5](https://www.uniprot.org/uniprot/Q9NYK5)</td></tr>
<tr><td><strong>Protein Class</strong></td><td>Pattern Recognition Receptor (TLR family)</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Alzheimer's Disease, Parkinson's Disease, Rheumatoid Arthritis, Viral Infections, Systemic Lupus Erythematosus</td></tr>
</table>
</div>

Overview

Mermaid diagram (expand to render)

TLR8 (Toll-Like Receptor 8) encodes an endosomal pattern recognition receptor that plays crucial roles in antiviral immunity and autoimmune responses. Located on the X chromosome at Xp22.2, TLR8 is primarily expressed in myeloid cells and recognizes single-stranded RNA (ssRNA) from viruses as well as synthetic antiviral compounds. Unlike TLR7, which is located on the X chromosome and escapes X-inactivation in females, TLR8 undergoes complete X-inactivation, leading to expression from only one allele in female cells. TLR8 has emerged as an important player in neurodegenerative diseases, particularly [Alzheimer's disease](/diseases/alzheimers-disease) and [Parkinson's disease](/diseases/parkinsons-disease), where it contributes to neuroinflammation through recognition of endogenous nucleic acids released from dying [neurons](/entities/neurons).

TLR8 belongs to the TLR7/8/9 subfamily of endosomal TLRs that specialize in nucleic acid recognition. These receptors are located primarily in endoplasmic reticulum-derived endosomes, where they survey for incoming pathogens. TLR8 forms functional homodimers upon ligand binding, similar to TLR7, but has distinct ligand specificity and expression patterns.

Protein Structure

Extracellular Domain

The TLR8 protein contains several distinctive structural features:

Leucine-rich repeat (LRR) domain: Consists of 25 LRR motifs that form the ligand-binding region
Z-loop: A unique insertion between LRR14 and LRR15 that undergoes proteolytic cleavage and is required for ligand recognition
Ligand-binding pocket: Recognizes guanosine- and uridine-rich ssRNA sequences
Glycosylation: Multiple N-linked glycosylation sites affect folding and trafficking

Transmembrane and Intracellular Domains

Single transmembrane helix: Contains a sorting motif for endosomal localization
TIR domain: Intracellular signaling domain approximately 200 amino acids
BB loop: Critical for adaptor protein interactions

Structural Insights

Crystal structures of TLR8 have revealed:

Dimerization mechanism: Two TLR8 monomers form a "m-shaped" dimer upon ligand binding
Ligand recognition: Small molecules and ssRNA bind in the central dimerization interface
Species differences: Human TLR8 has different agonist sensitivity compared to mouse TLR8

Normal Physiological Functions

Viral RNA Recognition

TLR8's primary function is detection of viral ssRNA:

Endosomal localization: TLR8 is retained in the endoplasmic reticulum and traffics to endosomes upon activation

Ligand delivery: Viral RNA is delivered to endosomes through endocytosis

Proteolytic processing: Endosomal proteases cleave TLR8, enabling ligand binding

Dimerization: Two cleaved TLR8 molecules dimerize with bound ligand

Signaling initiation: TIR domains dimerize and recruit adaptor proteins

Signaling Pathways

TLR8 activates innate immune signaling through multiple pathways:

| Pathway | Key Components | Outcome |
|---------|-----------------|---------|
| MyD88-dependent | MyD88 → IRAK4/1 → TRAF6 | [NF-κB](/entities/nf-kb), AP-1 activation |
| NF-κB pathway | TAK1 → IKK complex | Proinflammatory gene expression |
| MAPK pathway | ERK, JNK, p38 activation | Cytokine production, cell activation |
| IRF pathway | IRF7 activation | Type I interferon response |

Cellular Functions

TLR8 activation induces various immune cell responses:

Monocyte activation: Proinflammatory cytokine production (TNF-α, IL-6, IL-12)
Neutrophil activation: Enhanced survival and antimicrobial activity
Dendritic cell maturation: Increased co-stimulatory molecule expression
B cell activation: Enhanced antibody responses
T cell modulation: Can enhance or inhibit T cell responses

Expression Pattern

Immune Cell Expression

TLR8 shows distinctive expression in immune cells:

Monocytes/macrophages: High expression, primary responders
Neutrophils: High expression, rapid responses
Myeloid dendritic cells: Moderate to high expression
Plasmacytoid dendritic cells: Low expression (TLR7 dominates)
B cells: Low to moderate expression

Tissue Distribution

Highest expression: Peripheral blood leukocytes, spleen
High expression: Lung, liver
Moderate expression: Heart, placenta
Brain expression: Primarily [microglia](/cell-types/microglia-neuroinflammation) and infiltrating immune cells

Brain Expression

Within the central nervous system:

Microglia: Primary TLR8-expressing cells in the brain
Infiltrating monocytes: Contribute to neuroinflammation
Neurons: Very low or absent expression under normal conditions
[Astrocytes](/entities/astrocytes): Limited expression

Role in Neurodegeneration

Alzheimer's Disease

TLR8 has several connections to [Alzheimer's disease](/diseases/alzheimers-disease) pathogenesis:

Endogenous ligand recognition: May detect extracellular RNA from dying neurons
Microglial activation: TLR8 on microglia contributes to chronic neuroinflammation
Amyloid interaction: May modulate microglial responses to [amyloid-beta](/proteins/amyloid-beta) plaques
Autoimmune component: May recognize endogenous "self-RNA" in autoimmune contexts
Sex differences: X-chromosome location may contribute to sex-biased disease prevalence

Parkinson's Disease

TLR8 plays a role in [Parkinson's disease](/diseases/parkinsons-disease) through:

Nucleic acid release: Dying dopaminergic neurons release nucleic acids
Microglial TLR8: Recognizes extracellular RNA, triggering inflammation
[Alpha-synuclein](/proteins/alpha-synuclein) interaction: May recognize RNA bound to alpha-synuclein
Inflammatory cascade: Contributes to chronic neuroinflammation in substantia nigra
Sex-specific effects: X-chromosome location may explain some sex differences in PD

Rheumatoid Arthritis

Synovial expression: TLR8 is overexpressed in rheumatoid arthritis synovium
Joint inflammation: Contributes to inflammatory cascade in joints
Therapeutic target: TLR8 antagonists being investigated

Systemic Lupus Erythematosus (SLE)

Autoantibody generation: TLR8 activation may contribute to autoimmunity
Endogenous ligand recognition: May recognize self-RNA in immune complexes
Type I interferon: Contributes to the interferon signature in SLE

Molecular Mechanisms in Neurodegeneration

Neuroinflammation Pathways

TLR8 contributes to neuroinflammation through:

Microglial activation: Direct activation by extracellular RNA

Cytokine production: TNF-α, IL-1β, IL-6, and other proinflammatory mediators

Nitric oxide production: Induction of inducible nitric oxide synthase

[Reactive oxygen species](/entities/reactive-oxygen-species): NADPH oxidase activation

[Blood-brain barrier](/entities/blood-brain-barrier) disruption: Matrix metalloproteinase induction

Neuronal toxicity: Direct and indirect effects on neuron viability

Endogenous Ligands

TLR8 can be activated by endogenous ligands:

Extracellular RNA: Released from dying neurons
RNA-containing immune complexes: From autoimmune conditions
MicroRNA: Some studies suggest miRNA can activate TLR8
Altered self-RNA: Modified or mislocalized cellular RNA

This endogenous activation may contribute to sterile inflammation in neurodegeneration.

Therapeutic Targeting

TLR8 Antagonists

Several TLR8 antagonists are under development:

| Compound | Mechanism | Development Stage |
|----------|-----------|-------------------|
| CU-CPT8m | Small molecule antagonist | Preclinical |
| C909 | TLR8-specific antagonist | Research |
| Imidazoquinoline derivatives | Ligand competitors | Research |
| Oligonucleotide-based | Decoy TLR8 ligands | Research |

Anti-inflammatory Approaches

Natural compounds: Some flavonoids and terpenoids inhibit TLR8
Broad-spectrum TLR inhibitors: Target multiple TLRs including TLR8
downstream blockers: Target signaling molecules (TAK1, IKK)

Challenges

Immune suppression risk: Blocking TLR8 may impair antiviral immunity
Compartmentalization: Endosomal vs. cell surface TLR8 may differ
Redundancy: Other TLRs may compensate if TLR8 is blocked
Sex-specific effects: Need to consider X-inactivation in females

Genetic Variation

TLR8 Polymorphisms

Genetic variants in TLR8 affect function:

1-bp deletion (GT): Common variant affecting function in some populations
Missense variants: Various amino acid changes with functional consequences
Expression variants: Affect expression levels

These variants may influence susceptibility to infections and autoimmune diseases.

X-Chromosome Location

X-inactivation: TLR8 undergoes complete X-inactivation
Female mosaicism: Females express only one TLR8 allele per cell
Sex differences: May contribute to differences in immune responses between sexes

Research Directions

Current areas of active investigation include:

Selective antagonists: Developing TLR8-specific inhibitors with better profiles

Structural studies: Understanding TLR8 activation at atomic resolution

Biomarkers: TLR8 expression as a disease biomarker

Combination therapies: TLR8 inhibitors with other immunomodulators

Sex-specific approaches: Considering X-inactivation in therapy design

Key Publications

[Jurk et al., Human TLR7 or TLR8 confer responsiveness to R-848 (2002)](https://pubmed.ncbi.nlm.nih.gov/12055621/) — Original characterization of TLR8 function

[Bsibsi et al., Broad expression of TLRs in human CNS (2002)](https://pubmed.ncbi.nlm.nih.gov/12443839/) — TLR expression in brain

[Gorden et al., TLR7 and TLR8 have distinct ligand recognition (2006)](https://pubmed.ncbi.nlm.nih.gov/16625202/) — Structural basis for ligand specificity

[Heil et al., Species-specific recognition of ssRNA by TLR7 and TLR8 (2004)](https://pubmed.ncbi.nlm.nih.gov/15550249/) — Species differences

[Tanji et al., TLR8 structure reveals activation mechanism (2013)](https://pubmed.ncbi.nlm.nih.gov/23920654/) — Crystal structure of TLR8

Background

The study of Tlr8 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

[NCBI Gene: TLR8](https://www.ncbi.nlm.nih.gov/gene/51311)
[UniProt: TLR8](https://www.uniprot.org/uniprot/Q9NYK5)
[Ensembl: TLR8](https://www.ensembl.org/Homo_sapiens/ENSG00000101916)
[OMIM: TLR8](https://www.omim.org/entry/300366)
[IUPHAR/BPS Guide to Pharmacology: TLR8](https://www.guidetopharmacology.org/target/TLR8)

References

[Jurk et al., Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848 (2002) (2002)](https://pubmed.ncbi.nlm.nih.gov/12055621/)

[Bsibsi et al., Broad expression of Toll-like receptors in the human central nervous system (2002) (2002)](https://pubmed.ncbi.nlm.nih.gov/12443839/)

[Gorden et al., TLR7 and TLR8 have distinct ligand recognition (2006) (2006)](https://pubmed.ncbi.nlm.nih.gov/16625202/)

[Heil et al., Species-specific recognition of ssRNA by TLR7 and TLR8 (2004) (2004)](https://pubmed.ncbi.nlm.nih.gov/15550249/)

[Tanji et al., Structure of human TLR8 (2013) (2013)](https://pubmed.ncbi.nlm.nih.gov/23920654/)

[Unknown, Kawai and Akira, TLR signaling (2007) (2007)](https://pubmed.ncbi.nlm.nih.gov/17253978/)

[Heneka et al., Neuroinflammation in Alzheimer's disease (2015) (2015)](https://pubmed.ncbi.nlm.nih.gov/25666418/)

[Glass et al., Microglial identity and inflammatory responses in Alzheimer's disease (2010) (2010)](https://pubmed.ncbi.nlm.nih.gov/20421494/)

Pathway Diagram

The following diagram shows the key molecular relationships involving TLR8 Gene discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

TLR8

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-tlr8
kg_node_id	TLR8
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-fbaf861fa3fe
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-tlr8'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

35%

Debates

0

Incoming

7

Outgoing

21

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

TLR8 Gene

TLR8 Gene

Introduction

Overview

TLR8 Gene

Introduction

Overview

Protein Structure

Extracellular Domain

Transmembrane and Intracellular Domains

Structural Insights

Normal Physiological Functions

Viral RNA Recognition

Signaling Pathways

Cellular Functions

Expression Pattern

Immune Cell Expression

Tissue Distribution

Brain Expression

Role in Neurodegeneration

Alzheimer's Disease

Parkinson's Disease

Rheumatoid Arthritis

Systemic Lupus Erythematosus (SLE)

Molecular Mechanisms in Neurodegeneration

Neuroinflammation Pathways

Endogenous Ligands

Therapeutic Targeting

TLR8 Antagonists

Anti-inflammatory Approaches

Challenges

Genetic Variation

TLR8 Polymorphisms

X-Chromosome Location

Research Directions

Key Publications

Background

See Also

External Links

References

Pathway Diagram

💬 Discussion